ANIP
ANI Pharmaceuticals Inc

1,135
Mkt Cap
$1.85B
Volume
284,212.00
52W High
$99.50
52W Low
$54.10
PE Ratio
50.20
ANIP Fundamentals
Price
$81.85
Prev Close
$82.00
Open
$81.47
50D MA
$81.78
Beta
0.67
Avg. Volume
412,458.45
EPS (Annual)
-$1.04
P/B
3.64
Rev/Employee
$684,923.08
Loading...
Loading...
News
all
press releases
ANI Pharmaceuticals, Inc. $ANIP is Lisanti Capital Growth LLC's 5th Largest Position
Lisanti Capital Growth LLC decreased its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 13.3% in the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine analysts that are covering the firm, MarketBeat.com reports. Three...
MarketBeat·2d ago
News Placeholder
Implied Volatility Surging for ANI Pharmaceuticals Stock Options
Investors need to pay close attention to ANI Pharmaceuticals stock based on the movements in the options market lately.
Zacks·5d ago
News Placeholder
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Passes Below Fifty Day Moving Average - Here's What Happened
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Crosses Below 50-Day Moving Average - Here's Why...
MarketBeat·5d ago
News Placeholder
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Mizuho Markets Americas LLC
Mizuho Markets Americas LLC lessened its holdings in shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) by 15.2% in the third quarter, according to the company in its most recent filing...
MarketBeat·13d ago
News Placeholder
Campbell & CO Investment Adviser LLC Invests $1.60 Million in ANI Pharmaceuticals, Inc. $ANIP
Campbell & CO Investment Adviser LLC purchased a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Free Report) during the 3rd quarter, according to the company in its most recent filing with...
MarketBeat·15d ago
News Placeholder
Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?
Here is how ANI Pharmaceuticals (ANIP) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.
Zacks·16d ago
News Placeholder
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?
ANI Pharmaceuticals' rare disease growth, led by surging Cortrophin Gel sales, is outpacing Teva's slower sales momentum in this head-to-head stock comparison.
Zacks·16d ago
News Placeholder
ANIP Stock Rises 7% in a Week: Here's What You Should Know
ANI Pharmaceuticals jumps 7% as 2026 guidance tops expectations, with strong sales and EPS growth fueled by momentum in the rare disease franchise.
Zacks·17d ago
News Placeholder
Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) VP Meredith Cook sold 500 shares of the company's stock in a transaction on Tuesday, January 13th. The shares were sold at an average price...
MarketBeat·17d ago
<
1
2
...
>

Latest ANIP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.